
<DOC>
<DOCNO>WT01-B25-13</DOCNO>
<DOCOLDNO>IA031-000651-B019-173</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/schaffer/LIBRARY/studies/ledain/NONMED1.HTM 206.61.184.43 19970122122646 text/html 8025
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 12:26:36 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Saturday, 28-Dec-96 07:01:12 GMT
Content-length: 7808
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Canadian Government Commission of Inquiry - Table of
Contents</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body stylesrc="../../../../_private/schaffer_style.htm"
background="../../../../images/whttxtr2.jpg" bgcolor="#F2F2F2">
<!--webbot bot="Include"
u-include="../../../../_private/schaffer_logo.htm" tag="BODY"
startspan -->

<p align="center"><img src="../../../../images/schlogo_small.gif"
align="bottom" width="583" height="38"> </p>
<!--webbot bot="Include" endspan i-checksum="49253" --><!--webbot
bot="Include" u-include="../../../../_private/sch_navbar.htm"
tag="BODY" startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="61536" -->

<h1>THE NON-MEDICAL USE OF DRUGS </h1>

<h1>Interim Report of the Canadian Government Commission of
Inquiry </h1>

<hr>

<h2 align="center">CONTENTS </h2>

<h2><a href="nonmed1a.htm">Chapter 1. </a>THE COMMISSION'S
INTERPRETATION OF ITS TASK </h2>

<p>The Commission's Terms of References </p>

<p>The Implications of the Terms of Reference </p>

<p>Methods of Inquiry </p>

<p>The Role of the Interim Report </p>

<p>Staff and Research </p>

<h2><a href="nonmed2.htm">Chapter 2. </a>THE DRUGS AND THEIR
EFFECTS 29 </h2>

<h3>Introduction </h3>

<p>The Role of Science </p>

<p>The Classification of Drugs </p>

<p>Psychological Considerations </p>

<p>Pharmacological Considerations </p>

<p>Tolerance and Dependence </p>

<p>Scientific Methods </p>

<p>A Review of Selected Drugs </p>

<h3><a href="nonmed2a.htm">Barbiturates </a></h3>

<p>Medical Use </p>

<p>Administration, Absorption, Distribution and Physiological
Fate </p>

<p>Psychological Effects </p>

<p>Physiological Effects </p>

<p>Tolerance and Dependence </p>

<p>Barbiturates and Other Drugs </p>

<h3><a href="nonmed2b.htm">Alcohol </a></h3>

<p>Medical Use </p>

<p>Administration, Absorption, Distribution and Physiological
Fate </p>

<p>Short-Term Effects </p>

<p>Long-Term Effects </p>

<p>Tolerance and Dependence </p>

<p>Alcohol and Other Drugs </p>

<h3><a href="nonmed2c.htm">Minor Tranquillizers </a></h3>

<p>Medical Use </p>

<p>Administration, Absorption, Distribution, and Physiological
Fate </p>

<p>Psychological Effects </p>

<p>Physiological Effects </p>

<p>Tolerance and Dependence </p>

<p>Minor Tranquillizers and Other Drugs </p>

<h3><a href="nonmed2d.htm">Amphetamines</a> </h3>

<p>Medical Use </p>

<p>Administration, Absorption, Distribution and Physiological
Fate </p>

<p>Effects </p>

<p>Moderate-Dose Effects </p>

<p>Tolerance and Dependence with Moderate Doses </p>

<p>High-Dose Effects </p>

<p>High-Dose Dependency </p>

<p>'Speed Kills' </p>

<p>Amphetamines and Other Drugs </p>

<h3><a href="nonmed2e.htm">LSD </a></h3>

<p>Medical Use </p>

<p>Administration, Absorption, Distribution and Physiological
Fate </p>

<p>Psychological Effects </p>

<p>Physiological Effects </p>

<p>Tolerance and Dependence </p>

<p>LSD and Other Drugs </p>

<h3><a href="nonmed3.htm">Cannabis </a></h3>

<p>Medical Use </p>

<p>Administration, Absorption, Distribution and Physiological
Fate </p>

<p>Effects of Cannabis </p>

<p>Overview of Effects </p>

<p>Physiological Effects </p>

<p>Psychological Effects </p>

<p>Tolerance and Dependence </p>

<p>Cannabis and Other Drugs </p>

<p>Initiation of Cannabis Use </p>

<p>Some Cannabis Studies of Current Significance </p>

<p>I. The 'La Guardia Report' (1944) </p>

<p>II. Isbell <i>et al </i>(1967) </p>

<p>III. Weil, Zinberg and Nelsen (1969) </p>

<p>IV. Jones and Stone (1969) </p>

<p>V. Clark and Nakashima (1968) </p>

<p>VI. Crancer <i>et al </i>(1969) </p>

<p>VII. Robins <i>et al</i> (1969) </p>

<p>VIII. ARF's Marijuana Users Study (1970) </p>

<p>IX. Report of the Indian Hemp Drugs Commission (1894) </p>

<h3><a href="nonmed4.htm">Opiate Narcotics </a></h3>

<p>Medical Use </p>

<p>Administration, Absorption, Distribution and Physiological
Fate </p>

<p>Physiological Effects </p>

<p>Psychological Effects </p>

<p>Tolerance and Dependence </p>

<p>Opiate Narcotics and Crime </p>

<p>The Development of Dependence </p>

<p>Opiate Narcotics and Other Drugs </p>

<h3>Volatile Solvents </h3>

<p>Medical Use </p>

<p>Administration, Absorption, Distribution and Physiological
Fate </p>

<p>Effects </p>

<p>Tolerance and Dependence </p>

<p>Solvents and Other Drugs </p>

<h3>References and Selected Bibliography </h3>

<h2>Chapter 3. THE EXTENT AND PATTERNS OF NON-MEDICAL DRUG USE IN
CANADA </h2>

<p>Introduction </p>

<p>Alcohol </p>

<p>Barbiturates and Tranquillizers </p>

<p>The Barbiturates </p>

<p>The Minor Tranquillizers </p>

<p>The Amphetamines </p>

<p>The 'Speed' Phenomenon </p>

<p>LSD and Other Strong Hallucinogens </p>

<p>Cannabis </p>

<p>Opiate Narcotics </p>

<p>Solvents </p>

<p>References </p>

<h2><a href="nonmed7.htm">Chapter 4. </a>SOME CAUSES OF
NON-MEDICAL DRUG USE </h2>

<p>References </p>

<h2>Chapter 5. PRESENT CANADIAN POLICY - THE LAW </h2>

<p>Introduction </p>

<p>Law and Law Enforcement </p>

<p>Some Historical Background </p>

<p>International Framework </p>

<p>Constitutional Framework </p>

<p>Federal Legislation and its Enforcement </p>

<p>The Statutes and Administrative Regulations </p>

<p>The Role of Possession and Possessional Offences </p>

<p>Burden of Proof </p>

<p>The Definition of Trafficking </p>

<p>Methods of Enforcement </p>

<p>Sentencing Policy </p>

<p>Empirical Study of Law Enforcement and Correctional System </p>

<p>References </p>

<h2>Chapter 6. THE ISSUES - SOME INTERIM RECOMMENDATIONS </h2>

<p>Introduction </p>

<p>The Effects of the Drugs </p>

<p>General </p>

<p>Cannabis </p>

<p>LSD </p>

<p>Amphetamines </p>

<p>Multiple Drug Use </p>

<p>Drugs and Crime </p>

<p>Extent and Patterns of Non-Medical Drug Use </p>

<p>Causes of Non-Medical Drug Use </p>

<p>Social Response </p>

<p>Research, Information and Education </p>

<p>The Law </p>

<p>Treatment and Supportive Services </p>

<p>Prescribing Practices and Controls </p>

<p>Disagreement by M.-A. Bertrand </p>

<p>References </p>

<h3>Appendices: </h3>

<p><b>APPENDIX A.</b> Submissions to the Commission </p>

<p><b>APPENDIX B.</b> Letters from Private Citizens </p>

<p><b>APPENDIX C.</b> Commissioners and Staff </p>

<p><b>APPENDIX D.</b> Some Surveys of Drug Use Among Canadian
High School and University Students </p>

<p><b>APPENDIX E.</b> Current Research on Cannabis and Other
Drugs </p>

<p><b>APPENDIX F.</b> Innovative Services </p>

<p><b>GLOSSARY OF SCIENTIFIC AND TECHNICAL TERMS</b> <br>
</p>

<hr>
<!--webbot bot="Include"
u-include="../../../../_private/sch_navbar.htm" tag="BODY"
startspan -->

<p><a href="../../../../toc.htm">Contents</a> | <a
href="../../../../feedback.htm">Feedback</a> | <a
href="../../../../search.htm">Search</a> </p>

<p><a href="../../../../index.htm">DRCNet Library</a> | <a
href="../../../index.HTM">Schaffer Library</a>&nbsp;| <a
href="../studies.htm">Major Studies</a></p>
<!--webbot bot="Include" endspan i-checksum="61536" -->

<p>&nbsp;</p>
</body>
</html>
</DOC>